Raynaud

Raynaud
Name	Raynaud
Field	Rheumatology, Vascular medicine
Symptoms	Color changes of the skin, numbness, pain
Complications	Digital ulcers, gangrene
Onset	Any age, often adolescence or young adulthood
Causes	Vasospasm of digital arteries
Risks	Cold exposure, connective tissue disease, smoking
Diagnosis	Clinical examination, nailfold capillaroscopy
Treatment	Avoidance of triggers, vasodilators, surgery

Raynaud is a clinical phenomenon characterized by episodic vasospasm of peripheral arteries causing transient skin color changes and sensory disturbances, most commonly in the digits. It is encountered across specialties including Rheumatology, Vascular surgery, Dermatology, Internal medicine and is associated with systemic conditions such as Systemic sclerosis, Systemic lupus erythematosus, and Mixed connective tissue disease. Management involves trigger avoidance, pharmacologic vasodilation, and multidisciplinary care involving Occupational therapy and Pain management when needed.

Overview

Raynaud is categorized into primary and secondary forms; primary is idiopathic and benign while secondary arises in the context of disorders such as Systemic sclerosis, Rheumatoid arthritis, Systemic lupus erythematosus or following occupational exposures linked to Hand-arm vibration syndrome. Historical descriptions trace to clinicians in the 19th century and later pathophysiologic work informed by researchers in Vascular biology and Microcirculation. Care pathways often involve specialists from Angiology, Hand surgery, Endocrinology and allied services like Physiotherapy.

Signs and symptoms

Patients experience triphasic color changes—pallor, cyanosis, and reactive hyperemia—affecting fingers, toes, ears or nose during cold exposure or emotional stress. Associated sensory symptoms include numbness, paresthesia and throbbing pain; severe secondary disease may produce digital ulcers or gangrene requiring referral to Plastic surgery or Vascular surgery. Clinical assessment often documents provocation by cold water challenge and functional impact relevant to occupations such as those regulated by Occupational Safety and Health Administration or described in literature on Industrial medicine.

Causes and risk factors

Primary Raynaud occurs without an identifiable associated disease; risk factors include female sex, family history described in Genetics studies, and onset during adolescence. Secondary Raynaud is linked to autoimmune diseases like Systemic sclerosis, Sjogren syndrome, and Mixed connective tissue disease, to hematologic conditions such as Cryoglobulinemia and exposure-related causes including Vibration white finger from power tools or medications such as beta blockers and ergotamines described in pharmacoepidemiology reports. Other associations include infectious triggers documented in Infectious disease case series and occupational links explored by Epidemiology researchers.

Pathophysiology

Pathophysiology involves dysregulation of vascular tone with exaggerated vasoconstriction of digital arterioles and cutaneous microcirculation mediated by neural, endothelial and smooth muscle mechanisms. Key mediators include sympathetic adrenergic pathways, endothelin described in Cardiovascular research, nitric oxide pathways from Endothelial cell studies, and structural vascular changes observed in connective tissue disease cohorts such as those with Systemic sclerosis. Microvascular imaging with nailfold capillaroscopy and histopathology reported in Pathology literature reveal capillary dropout, microhemorrhages and fibrosis in secondary forms.

Diagnosis

Diagnosis is clinical, supported by history, examination and investigations including nailfold capillaroscopy, thermography used in Nuclear medicine and vascular studies such as digital plethysmography and Doppler ultrasonography performed by Radiology departments. Serologic testing for autoantibodies like anti-centromere and anti-Scl-70 antibodies involves laboratory services aligned with Immunology and Clinical pathology. Differential diagnoses considered by specialists include peripheral arterial disease evaluated by Cardiology teams, embolic phenomena from Hematology sources, and cold agglutinin disease assessed in Infectious disease and hematology settings.

Management and treatment

Management emphasizes nonpharmacologic strategies: avoidance of cold, smoking cessation supported by Public health programs, hand protection advised by Occupational therapy and behavioural measures from Psychology for stress reduction. Pharmacologic treatment for persistent or severe disease includes calcium channel blockers such as agents evaluated in Pharmacology trials, topical nitrates, phosphodiesterase inhibitors studied in Clinical trials, prostacyclin analogs administered in tertiary centers, and endothelin receptor antagonists used for refractory cases in the context of Systemic sclerosis guidelines. Interventional options include botulinum toxin injection trials reported in Plastic surgery literature and surgical sympathectomy performed by Vascular surgery or Thoracic surgery teams for selected patients. Wound care for digital ulcers involves referrals to Wound care clinics and multidisciplinary coordination with Infectious disease and Plastic surgery when debridement or reconstruction is required.

Epidemiology and prognosis

Epidemiologic studies indicate a prevalence of primary Raynaud in populations studied by Public health and Epidemiology researchers, with higher frequency among women and in temperate climates catalogued in population surveys. Secondary Raynaud prevalence parallels rates of underlying diseases such as Systemic sclerosis within cohorts followed by Rheumatology registries. Prognosis for primary Raynaud is generally benign with low risk of tissue loss, whereas secondary Raynaud prognosis depends on the underlying disorder and is influenced by comorbidities managed by Internal medicine and specialty services; severe cases carry risk of digital ischemia, ulceration and amputation addressed in Surgery literature.

Category:Vascular diseases